Literature DB >> 2459414

Functional organization of the murine leukemia virus reverse transcriptase: characterization of a bacterially expressed AKR DNA polymerase deficient in RNase H activity.

J G Levin1, R J Crouch, K Post, S C Hu, D McKelvin, M Zweig, D L Court, B I Gerwin.   

Abstract

The functional organization of the murine leukemia virus reverse transcriptase was investigated by expressing a molecular clone containing AKR MuLV reverse transcriptase-coding sequences in Escherichia coli. A purified preparation of the expressed enzyme (pRT250 reverse transcriptase) consisted primarily of a 69-kilodalton protein that has normal levels of murine leukemia virus polymerase activity but 10-fold-reduced levels of RNase H compared with the viral enzyme. The deficit in RNase H activity was correlated with the absence of 60 to 65 amino acids normally present at the carboxyl end of murine leukemia virus reverse transcriptase. The results provide additional experimental evidence for the localization of polymerase and RNase H domains to the N- and C-terminal regions of reverse transcriptase, respectively.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459414      PMCID: PMC253878     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Alkylation and identification of the histidine residues at the active site of ribonuclease.

Authors:  A M CRESTFIELD; W H STEIN; S MOORE
Journal:  J Biol Chem       Date:  1963-07       Impact factor: 5.157

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Degradation of DNA RNA hybrids by ribonuclease H and DNA polymerases of cellular and viral origin.

Authors:  W Keller; R Crouch
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

4.  Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids.

Authors:  K Mölling; D P Bolognesi; H Bauer; W Büsen; H W Plassmann; P Hausen
Journal:  Nat New Biol       Date:  1971-12-22

5.  Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D.

Authors:  J G Levin; P M Grimley; J M Ramseur; I K Berezesky
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

6.  Interactions of murine leukemia virus core components: characterization of reverse transcriptase packaged in the absence of 70S genomic RNA.

Authors:  B I Gerwin; J G Levin
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

7.  Further characterization of the Friend murine leukemia virus reverse transcriptase-RNase H complex.

Authors:  K Moelling
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

8.  Mechanism of action of ribonuclease H isolated from avian myeloblastosis virus and Escherichia coli.

Authors:  J P Leis; I Berkower; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

9.  Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity.

Authors:  M H Lai; I M Verma
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

10.  Isolation and characterization of two enzymatic activities from chick embryos which degrade double-stranded RNA.

Authors:  S H Hall; R J Crouch
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

View more
  13 in total

1.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching.

Authors:  C K Hwang; E S Svarovskaia; V K Pathak
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

3.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

4.  Correlation of activity with phenotypes of Escherichia coli partial function mutants of rnh, the gene encoding RNase H.

Authors:  M Itaya; R J Crouch
Journal:  Mol Gen Genet       Date:  1991-07

5.  Suppression of UAA and UGA termination codons in mutant murine leukemia viruses.

Authors:  Y X Feng; J G Levin; D L Hatfield; T S Schaefer; R J Gorelick; A Rein
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  Translational readthrough of the murine leukemia virus gag gene amber codon does not require virus-induced alteration of tRNA.

Authors:  Y X Feng; D L Hatfield; A Rein; J G Levin
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcription.

Authors:  O Dhellin; J Maestre; T Heidmann
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

8.  Molecular cloning of a ribonuclease H (RNase HI) gene from an extreme thermophile Thermus thermophilus HB8: a thermostable RNase H can functionally replace the Escherichia coli enzyme in vivo.

Authors:  M Itaya; K Kondo
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

9.  Selective cloning of genes encoding RNase H from Salmonella typhimurium, Saccharomyces cerevisiae and Escherichia coli rnh mutant.

Authors:  M Itaya; D McKelvin; S K Chatterjie; R J Crouch
Journal:  Mol Gen Genet       Date:  1991-07

10.  Influence of the RNase H domain of retroviral reverse transcriptases on the metal specificity and substrate selection of their polymerase domains.

Authors:  Tanaji T Talele; Alok Upadhyay; Virendra N Pandey
Journal:  Virol J       Date:  2009-10-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.